OraSure Technologies | OSUR - Operating Profit


OraSure Technologies reported $-13.59M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agilent USD 444M 45M Jun/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Becton, Dickinson and Co. USD 1.11B 357M Sep/2026
Bio Techne USD 55.82M 39.18M Sep/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Bruker USD 83.5M 13.9M Sep/2026
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 202.64M 82.75M Sep/2026
Danaher USD 1.25B 118M Sep/2026
Dentsply International USD 38M 46M Sep/2026
Dexcom USD 318.3M 63M Jun/2026
Illumina USD 305M 45M Sep/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD 12.1M 27.4M Sep/2026
Repligen USD 24.31M 3.18M Sep/2026
Revvity USD 124.63M 1.51M Sep/2026
STAAR Surgical USD 5.46M 4.64M Sep/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Trinity Biotech USD -1.79M 481K Mar/2026
Waters USD -86M 234M Jun/2026